The ENPP1 gene helps your body control mineral balance by making a protein that limits calcium buildup in blood vessels and soft tissues and supports healthy bones. If this gene does not work properly, some people develop abnormal calcification, low phosphate levels, bone pain, weak bones, or growth problems, sometimes starting in infancy. Pathogenic variants in the ENPP1 gene are linked to rare inherited conditions such as generalized arterial calcification of infancy and ENPP1 related low phosphate rickets.
What is a gene?
Genes are segments of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the functional parts of cells. Others mainly control when certain processes take place, where they occur, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
ENPP1Gene function
What if the gene works
The ENPP1 gene helps your body make pyrophosphate, a natural substance that limits extra calcium deposits in soft tissues and blood vessels. It also plays a part in cell signaling, including how some tissues respond to insulin.
Risk
What if the gene does not work
Variants in the ENPP1 gene can lead to abnormal calcium buildup in arteries or low phosphate bone disease with soft, painful bones. Milder and more severe variants can affect when problems begin, how severe they are, and which features appear.
Treatment
What does that mean for your treatment
No ENPP1-specific treatment or drug-selection approach is currently established in clinical guidelines. Targeted therapy is under study, including ENPP1 enzyme replacement to raise pyrophosphate, which may help limit abnormal calcification.
Conditions associated with ENPP1
Gene function
What if the gene works
Your cells use the ENPP1 gene to manage chemical signals outside the cell and keep mineral deposits under control. Its protein sits on the cell surface, where it breaks down ATP, a common energy carrying molecule. This process makes pyrophosphate, which helps keep calcium from building up in soft tissues and blood vessel walls.
ENPP1 makes a surface enzyme that breaks down ATP outside cells. This step creates smaller molecules, including pyrophosphate, that help support normal body chemistry.
By making pyrophosphate, the ENPP1 gene helps keep calcium and phosphate from settling where they do not belong. This supports healthy mineral balance in blood vessel walls, joints, and other soft tissues.
ATP outside cells can also act as a chemical signal between nearby cells. ENPP1 helps fine tune that signaling by clearing some ATP from the space around cells.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Different variants in the ENPP1 gene can reduce the amount of working protein, distort its shape, or weaken enzyme activity at the cell surface. How variants in the ENPP1 gene affect protein function ranges from partial loss to near-complete loss, with milder variants leaving some activity and more severe variants sharply lowering it. This range can help explain why linked conditions may start earlier or be more severe in some people.
How variants are linked to conditions
Pathogenic variants in the ENPP1 gene are best known for causing generalized arterial calcification of infancy, a rare condition with calcium buildup in blood vessels early in life. They can also cause autosomal recessive hypophosphatemic rickets type 2, which affects bone strength and growth. In practice, ENPP1 gene variants linked to conditions most often fall within this rare blood vessel and bone disease spectrum.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences between people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ENPP1, risk is mostly shaped by inheritance rather than lifestyle. A child’s chance is higher when both parents carry a harmful ENPP1 change, and the chance can also be higher in families where parents are blood relatives. There is not enough evidence to say that diet, exercise, or other everyday habits lower this genetic risk.
Inheritance of ENPP1 variants
The inheritance pattern for ENPP1-related conditions can differ depending on the specific condition and gene change. Most well-known ENPP1-related conditions, including generalized arterial calcification of infancy and ENPP1-related hypophosphatemic rickets, follow an autosomal recessive pattern, which means a child inherits one ENPP1 variant from each parent. In that setting, parents are usually healthy carriers, and each pregnancy has a 25% chance of being affected. A separate skin condition linked to the ENPP1 gene, called Cole disease, follows an autosomal dominant pattern, so one altered copy can be enough and it can pass from either parent to a child.
What does my ENPP1 result mean for my family?
For ENPP1-related conditions, the family pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, so relatives may want to learn whether the same gene change runs in the family. Children of someone with an ENPP1-related condition will usually be carriers unless the other parent also carries an ENPP1 change.
Genetic information
Genetic testing
How you find out about variants
To check for changes in the ENPP1 gene, clinicians use genetic testing for ENPP1 variants, usually with a blood or saliva sample. A lab reads the gene's DNA code to look for variants and reports whether a finding helps confirm a diagnosis, carrier status, or the cause of unexplained symptoms.
When should I consider getting a genetic test?
Consider ENPP1 testing if a baby has unusual calcium buildup in the arteries, or if someone has ongoing low phosphate with soft or painful bones, bowing of the legs, or repeated fractures. It can also help if these problems run in the family or if both parents are known carriers.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the specific type of variant. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, seem less effective for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can shape their response to medicines. It focuses on gene drug patterns to help explain why the same treatment may not work in the same way for everyone. With many medications, genes can influence both how powerfully a drug works and how the body handles it. This understanding can support treatment decisions that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ENPP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
Researchers identified the ENPP1 gene in the 1990s while studying a cell surface protein first known as PC-1. Early work linked it to insulin signaling and tissue calcification, which helped bring the gene into wider medical research. From these first observations, research expanded steadily. In the 2000s, pathogenic variants in the ENPP1 gene were found to cause generalized arterial calcification of infancy, a landmark step for families affected by this rare condition. Later studies showed that ENPP1-related changes can also be involved in phosphate problems and childhood bone disease, broadening how clinicians understood its role. Over time, descriptions became more precise as genetic testing connected earlier clinical reports to the same gene.